Real World Study of Pyrotinib in Human Epidermal Growth Factor Receptor-2 (HER2) Positive Breast Cancer
Clinical trial NCT04158505 · UNKNOWN
Trial details
- NCT number
- NCT04158505
- Sponsor
- Chinese Academy of Medical Sciences
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2020-02-28
- Primary completion
- 2021-11-15
- Enrollment
- 3000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.